相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The real-world outcomes of multiple myeloma patients treated with daratumumab
Agoston Gyula Szabo et al.
PLOS ONE (2021)
Real-world effectiveness and safety of daratumumab, bortezomib, and dexamethasone in relapsed/refractory multiple myeloma in Slovakia
L'ubica Harvanova et al.
NEOPLASMA (2021)
Impact of performance status on overall survival in patients with relapsed and/or refractory multiple myeloma: Real-life outcomes of daratumumab treatment
Garbriel Afram et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy
Ujjawal H. Gandhi et al.
LEUKEMIA (2019)
Efficacy of daratumumab monotherapy in real-world heavily pretreated patients with relapsed or refractory multiple myeloma
Aleksander Salomon-Perzynski et al.
ADVANCES IN MEDICAL SCIENCES (2019)
Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients
Szilvia Lovas et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)